Vaš brskalnik ne omogoča JavaScript!
JavaScript je nujen za pravilno delovanje teh spletnih strani. Omogočite JavaScript ali pa uporabite sodobnejši brskalnik.
Nacionalni portal odprte znanosti
Odprta znanost
DiKUL
slv
|
eng
Iskanje
Brskanje
Novo v RUL
Kaj je RUL
V številkah
Pomoč
Prijava
Regulation of oxygen homeostasis at the intestinal epithelial barrier site
ID
Konjar, Špela
(
Avtor
),
ID
Pavšič, Miha
(
Avtor
),
ID
Veldhoen, Marc
(
Avtor
)
PDF - Predstavitvena datoteka,
prenos
(1,44 MB)
MD5: AB787802E4FCE02E03ED6E947BC8FC4F
URL - Izvorni URL, za dostop obiščite
https://www.mdpi.com/1422-0067/22/17/9170
Galerija slik
Izvleček
The unique biology of the intestinal epithelial barrier is linked to a low baseline oxygen pressure (pO$_2$), characterised by a high rate of metabolites circulating through the intestinal blood and the presence of a steep oxygen gradient across the epithelial surface. These characteristics require tight regulation of oxygen homeostasis, achieved in part by hypoxia-inducible factor (HIF)-dependent signalling. Furthermore, intestinal epithelial cells (IEC) possess metabolic identities that are reflected in changes in mitochondrial function. In recent years, it has become widely accepted that oxygen metabolism is key to homeostasis at the mucosae. In addition, the gut has a vast and diverse microbial population, the microbiota. Microbiome–gut communication represents a dynamic exchange of mediators produced by bacterial and intestinal metabolism. The microbiome contributes to the maintenance of the hypoxic environment, which is critical for nutrient absorption, intestinal barrier function, and innate and/or adaptive immune responses in the gastrointestinal tract. In this review, we focus on oxygen homeostasis at the epithelial barrier site, how it is regulated by hypoxia and the microbiome, and how oxygen homeostasis at the epithelium is regulated in health and disease.
Jezik:
Angleški jezik
Ključne besede:
oxygen
,
mitochondria
,
hypoxia
,
microbiota
,
IBD
Vrsta gradiva:
Članek v reviji
Tipologija:
1.02 - Pregledni znanstveni članek
Organizacija:
FKKT - Fakulteta za kemijo in kemijsko tehnologijo
Status publikacije:
Objavljeno
Različica publikacije:
Objavljena publikacija
Leto izida:
2021
Št. strani:
15 str.
Številčenje:
Vol. 22, iss. 17, art. 9170
PID:
20.500.12556/RUL-135586
UDK:
577.2:616.34
ISSN pri članku:
1422-0067
DOI:
10.3390/ijms22179170
COBISS.SI-ID:
74311427
Datum objave v RUL:
21.03.2022
Število ogledov:
886
Število prenosov:
123
Metapodatki:
Citiraj gradivo
Navadno besedilo
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Kopiraj citat
Objavi na:
Gradivo je del revije
Naslov:
International journal of molecular sciences
Skrajšan naslov:
Int. j. mol. sci.
Založnik:
MDPI
ISSN:
1422-0067
COBISS.SI-ID:
2779162
Licence
Licenca:
CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:
http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:
To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.
Začetek licenciranja:
01.09.2021
Sekundarni jezik
Jezik:
Slovenski jezik
Ključne besede:
kisik
,
mitohondriji
,
hipoksija
,
mikrobiota
,
bolezni črevesja
Projekti
Financer:
Drugi - Drug financer ali več financerjev
Program financ.:
Public Scholarship, Development, Disability Fund of the Republic of Slovenia
Financer:
ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:
P1-0207
Naslov:
Toksini in biomembrane
Financer:
EC - European Commission
Program financ.:
H2020
Številka projekta:
667824
Naslov:
Leverage research EXCELLence and INNOVation potential of Instituto de Medicina Molecular (IMM) through translational biomedical research in immunity and infection
Akronim:
EXCELLtoINNOV
Financer:
Drugi - Drug financer ali več financerjev
Program financ.:
“La Caixa” Foundation
Številka projekta:
LCF/PR/HR19/52160005
Podobna dela
Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:
Nazaj